Cullinan Associates’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$569K Hold
4,700
0.04% 162
2025
Q1
$524K Hold
4,700
0.04% 159
2024
Q4
$457K Hold
4,700
0.03% 171
2024
Q3
$544K Hold
4,700
0.03% 173
2024
Q2
$500K Hold
4,700
0.03% 183
2024
Q1
$455K Buy
4,700
+100
+2% +$9.67K 0.03% 194
2023
Q4
$464K Sell
4,600
-200
-4% -$20.2K 0.03% 186
2023
Q3
$489K Hold
4,800
0.03% 190
2023
Q2
$484K Buy
4,800
+200
+4% +$20.2K 0.03% 196
2023
Q1
$423K Sell
4,600
-1,296
-22% -$119K 0.02% 201
2022
Q4
$535K Buy
5,896
+1,196
+25% +$109K 0.03% 200
2022
Q3
$357K Buy
4,700
+200
+4% +$15.2K 0.02% 193
2022
Q2
$380K Hold
4,500
0.02% 189
2022
Q1
$395K Sell
4,500
-165
-4% -$14.5K 0.02% 191
2021
Q4
$408K Sell
4,665
-1,300
-22% -$114K 0.02% 193
2021
Q3
$488K Buy
5,965
+165
+3% +$13.5K 0.03% 183
2021
Q2
$529K Sell
5,800
-112
-2% -$10.2K 0.03% 171
2021
Q1
$505K Hold
5,912
0.03% 157
2020
Q4
$558K Hold
5,912
0.03% 142
2020
Q3
$514K Hold
5,912
0.03% 140
2020
Q2
$516K Buy
5,912
+380
+7% +$33.2K 0.04% 134
2020
Q1
$456K Sell
5,532
-544
-9% -$44.8K 0.04% 134
2019
Q4
$575K Buy
6,076
+1,464
+32% +$139K 0.04% 138
2019
Q3
$401K Hold
4,612
0.03% 146
2019
Q2
$421K Sell
4,612
-535
-10% -$48.8K 0.03% 153
2019
Q1
$443K Hold
5,147
0.03% 151
2018
Q4
$396K Buy
5,147
+1,129
+28% +$86.9K 0.03% 148
2018
Q3
$310K Hold
4,018
0.02% 165
2018
Q2
$272K Hold
4,018
0.02% 170
2018
Q1
$291K Hold
4,018
0.02% 167
2017
Q4
$302K Hold
4,018
0.02% 168
2017
Q3
$309K Hold
4,018
0.02% 172
2017
Q2
$300K Hold
4,018
0.02% 179
2017
Q1
$267K Sell
4,018
-39
-1% -$2.59K 0.02% 183
2016
Q4
$265K Buy
4,057
+39
+1% +$2.55K 0.02% 182
2016
Q3
$284K Hold
4,018
0.02% 179
2016
Q2
$297K Hold
4,018
0.02% 178
2016
Q1
$261K Buy
4,018
+1,228
+44% +$79.8K 0.02% 180
2015
Q4
$215K Hold
2,790
0.02% 191
2015
Q3
$230K Hold
2,790
0.02% 202
2015
Q2
$246K Hold
2,790
0.02% 200
2015
Q1
$247K Buy
+2,790
New +$247K 0.02% 206